Concord Drugs (BOM:538965) Long-Term Debt : ₹0.0 Mil (As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Concord Drugs Long-Term Debt?

Concord Drugs's Long-Term Debt for the quarter that ended in Dec. 2023 was ₹0.0 Mil.

Concord Drugs's quarterly Long-Term Debt increased from Jun. 2023 (₹0.0 Mil) to Sep. 2023 (₹20.5 Mil) but then declined from Sep. 2023 (₹20.5 Mil) to Dec. 2023 (₹0.0 Mil).

Concord Drugs's annual Long-Term Debt declined from Mar. 2021 (₹37.5 Mil) to Mar. 2022 (₹16.9 Mil) but then increased from Mar. 2022 (₹16.9 Mil) to Mar. 2023 (₹19.1 Mil).

Concord Drugs Long-Term Debt Historical Data

The historical data trend for Concord Drugs's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Concord Drugs Long-Term Debt Chart

Concord Drugs Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Long-Term Debt

Get a 7-Day Free Trial

6.90

8.77

37.51

16.95

19.11

Concord Drugs Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Long-Term Debt	Get a 7-Day Free Trial															-	19.11	-	20.46	-

Concord Drugs (BOM:538965) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Concord Drugs Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Concord Drugs's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Concord Drugs (BOM:538965) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Concord Drugs Ltd (BOM:538965) » Definitions » Long-Term Debt

Traded in Other Exchanges

N/A

Address

3-11-451, L B Nagar, Hayatnagar Mandal, Hyderabad, TG, IND, 500074

Website

https://www.concorddrugs.in

Concord Drugs Ltd is an India based pharmaceutical company. The principal activity of the company is to manufacture licensed drugs based on the formulations approved. Its product portfolio includes Pharmaceutical Ready to fill Pellets, MUPS ((Multiple Unit Pellets System); Tissue Bio Adhesive; Injectables (Small Volume Parenterals); Capsules; Liquid Orals (Syrups & Suspensions); Dry Syrups (Powder) and Hand Sanitizers. Geographically, it operates only in India.

Concord Drugs (BOM:538965) Headlines

No Headlines